| CAS: | 630-93-3 | |||||||||||||||||||||||||||||||||||||||||||||||
| 分子式: | C15H11NaN2O2 | |||||||||||||||||||||||||||||||||||||||||||||||
| 分子量: | 274.25 | |||||||||||||||||||||||||||||||||||||||||||||||
| 中文名称: |
| |||||||||||||||||||||||||||||||||||||||||||||||
| 英文名称: |
| |||||||||||||||||||||||||||||||||||||||||||||||
| 性质描述: | 白色粉末。易溶于水,溶于乙醇,几乎不溶于乙醚、氯仿。在空气中渐渐吸收二氧化碳而析出苯妥英。苯妥英熔点295-598℃,不溶于水,无臭,味苦。 | |||||||||||||||||||||||||||||||||||||||||||||||
| 生产方法: | 苯甲醛经缩合、氧化得到联苯甲酰,然后与尿素重排、环合得到苯妥英钠。将水、尿素及联苯甲酰依次加入反应锅,搅拌加热至98℃,加入30%氢氧化钠,回流1.5h。加水及适量少性炭脱色,冷至26-28℃,过滤,滤液用5%左右盐酸酸化至pH=5-6,温度45-55℃,过滤,用水洗涤,得苯妥英。将苯妥英投入碱液中加热溶解,用氢氧化钠溶液调节pH至11-11.5,加活万籁 炭于75-80℃脱色半小时。压滤,冷至37-38℃,加入晶种放置结晶。冷至25℃过滤,结晶用蒸馏水洗涤,甩干,粉碎,于80℃左右干燥,得苯妥英钠。 | |||||||||||||||||||||||||||||||||||||||||||||||
| 用途: | 抗癫痫药及抗心律失常药。对癫痫大发作疗效好,对精神运动性发作和局限性发作次之,对小发作不但无效,甚至能诱发。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D807132 | MACKLIN | 苯妥英钠 | 98% | 54元/25g; 148元/100g; 643元/500g; 2802元/2.5kg; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:室温 状态:白色到浅黄色粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D792855 | MACKLIN | 苯妥英钠 | 10mM in DMSO | 479元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D1331 | TCI | Phenytoin Sodium | >98.0%(T) | 390元/25G; 1435元/500G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 365720 | J&K | Phenytoin Sodium | 98%, 一种有效的多通道阻断剂 | 232元/25G; 700元/100G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Phenytoin Sodium是一种失活的电压门控钠离子通道稳定剂。 靶点(IC50 & Targe) Sodium Channel 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| C43610 | Alfa Aesar | 5,5-Diphenylhydantoin Sodium Salt | 99% | 672元/25g; 2309元/100g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息 Ref# MDL 分子式 分子量 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1492 | Supelco | Phenytoin Sodium | Pharmaceutical Secondary Standard; Certified Reference Material | 1392.96元/1 G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. 生化/生理作用 减少癫痫大发作的发生率;可能通过 Na+、K+ 和 Ca2+ 通道的影响而稳定可兴奋膜。 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA3040 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P1300000 | Phenytoin Sodium | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 减少癫痫大发作的发生率;可能通过 Na+、K+ 和 Ca2+ 通道的影响而稳定可兴奋膜。 包装 Unit quantity: 250 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| D4505 | Sigma-Aldrich | 5,5-Diphenylhydantoin Sodium Salt | ≥99% | 787.89元/25 G; 1649.92元/100 G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 5,5-Diphenylhydantoin sodium salt is a derivative of phenytoin. 5,5-Diphenylhydantoin is used for treating epilepsy and has antiepileptic activity. It functions by blocking the sodium channels and modulates excitation of neurons. However, the side effects include hypertrichosis and overgrowth of gum tissue around the teeth. It promotes proliferation of the neural stem cells by modulating growth factors. Diphenylhydantoin is toxic and induces apoptosis in cultured cerebellar granule neurons. 应用 5,5-Diphenylhydantoin sodium salt has been used:
生化/生理作用 减少癫痫大发作的发生率;可能通过 Na+、K+ 和 Ca2+ 通道的影响而稳定可兴奋膜。 特点和优势 This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1535507 | USP | Phenytoin Sodium | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Phenytoin sodium is an anti-epileptic drug, which belongs to the hydantoin family. 生化/生理作用 减少癫痫大发作的发生率;可能通过 Na+、K+ 和 Ca2+ 通道的影响而稳定可兴奋膜。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||